Efficacy and Safety of Omalizumab (Xolair) for Cholinergic Urticaria in Patients Unresponsive to a Double Dose of Antihistamines: A Randomized Mixed Double-Blind and Open-Label Placebo-Controlled Clinical Trial

Gastaminza, G; Azofra, J; Nunez-Cordoba, JM; Baeza, ML; Echechipia, S; Gaig, P; Garcia, BE; Labrador-Horrillo, M; Sala-Cunill, A; Bresco, MS; Beristain, A; Quinones, D; Donado, CD; Zubeldia, JM; Ferrer, M

Ferrer, M (reprint author), Univ Navarra, Dept Allergy Clin, Pio 12,36, Pamplona 31008, Spain.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019; 7 (5): 1599

Abstract

BACKGROUND: Cholinergic urticaria (UCOL) is a highly disabling inducible urticaria triggered by an increase in core body temperature. OBJECTIVE: To ex......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索